Share on Pinterest Could a nasal spray help delay Alzheimer’s onset in the future? Image credit: Grace Cary/Getty Images. The number of people with dementia is forecast to almost triple by 2050.

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal irritation ...

15 Is Nasal Spray Addictive? The National Institute of Drug Abuse defines drug addiction as a persistent neurological condition that leads to an uncontrollable reliance on drugs, even when the use ...

But there’s a brand new medicine available for that. It’s called Timolol nasal spray and was developed in Kansas City. Doctors at North Kansas City Hospital found the same liquid in Timolol ...

Conclusion: Dexmedetomidine nasal spray was well tolerated and achieved satisfactory sedation in the dose range of 25–200 μg in Chinese healthy male and female subjects. Dexmedetomidine hydrochloride ...

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the standard oral and intravenous formulations of the medication ...

Medscape Medical News, May 21, 2019 Alert FDA OKs Midazolam Nasal Spray (Nayzilam) for Seizure Clusters Nayzilam is the first FDA-approved nasal option for treating seizure clusters that are ...

This study provides a useful set of experiments showing the relative contribution of the noradrenergic system in reversing the sedation induced by midazolam. The evidence supporting the claims of the ...

We think UCB is in good financial health, with solid earnings and cash flow generation. UCB has deleveraged over the years, and it ended 2023 with about EUR 2.2 billion in net debt on its balance ...